GLP-3

Description

Retatrutide (GLP-1/GIP/Glucagon Receptor Tri-Agonist)

Molecular Formula: C₁₈₇H₂₈₆N₄₆O₅₉
Molecular Weight: 4,766.54 g/mol
Sequence: [Specify if known or leave blank for catalog entry]
CAS Number: [Pending / Not Assigned]
Purity: ≥98% (HPLC)
Form: Lyophilized Powder
Storage: Store at −20°C. Protect from light and moisture.

Description

Retatrutide is a synthetic tri-agonist peptide that simultaneously activates the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This multi-target mechanism has made it a compound of significant scientific interest for studies involving energy metabolism, lipid regulation, glucose control, and adiposity modulation.

Preclinical data indicate that GLP-1 and GIP receptor co-activation enhances insulin sensitivity and appetite regulation, while glucagon receptor engagement promotes increased energy expenditure. The synergistic receptor activation profile of Retatrutide allows researchers to explore the combined effects of incretin and glucagon pathways on metabolic signaling, nutrient utilization, and thermogenesis.

Intended Use

This product is intended for laboratory research use only.
It is not for human consumption, diagnostic, or therapeutic purposes.
All handling should be performed by qualified professionals in a controlled research environment.

Key Research Applications

• Investigation of metabolic pathway modulation

• Studies on energy balance and weight regulation

• Analysis of glucose homeostasis mechanisms

• Research on peptide receptor interactions